Francesca Sperandi

5PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

|Jun 13, 2025
Efficacy and Safety of TROP-2-Targeting Antibody-Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data.

Sara Stumpo, Andrea Carlini, Francesco Mantuano

|Dec 05, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations.

Alessandro Di Federico, Stefania Angelicola, Mariateresa Frascino

|Sep 23, 2022
Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC).

Andrea De Giglio, Marta Aprile, Alessandro Di Federico

|Jan 21, 2022
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma.

Francesca Comito, Rachele Pagani, Giada Grilli

Pageof 1

Frequent Collaborators

4 joint publications

Andrea De Giglio

4 joint publications

Alessandro Di Federico

3 joint publications

Francesco Gelsomino

2 joint publications

Barbara Melotti